Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew J Winston

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Transplantation|February 15, 2021
Association of HHV-6 With Outcomes in CMV-seronegative Liver Transplant Recipients With CMV-seropositive Donors Receiving Preemptive Antiviral TherapyNina Singh, Drew J Winston, Raymund R Razonable, et al.
JAMA|April 15, 2020
Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical TrialNina Singh, Drew J Winston, Raymund R Razonable, et al.
Transplantation|April 18, 2020
Liver Transplantation in Patients With Pretransplant Aspergillus Colonization: Is It Safe to Proceed?Arpit Amin, Alfonso Molina, Lisa Quach, et al.
The New England Journal of Medicine|September 27, 2013
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantationFrancisco M Marty, Drew J Winston, Scott D Rowley, et al.
JCI Insight|August 5, 2024
Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxisDanniel Zamora, Sayan Dasgupta, Terry Stevens-Ayers, et al.
The Journal of Infectious Diseases|September 20, 2024
Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus InfectionSunwen Chou, Drew J Winston, Robin K Avery, et al.
Microorganisms|August 26, 2023
Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic InvestigationShangxin Yang, Ashrit Multani, Jacob M Garrigues, et al.
The New England Journal of Medicine|January 26, 2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropeniaOliver A Cornely, Johan Maertens, Drew J Winston, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2023
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With ValganciclovirGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Transplantation|May 16, 2014
Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic featuresDrew J Winston, Holenarasipur R Vikram, Ingrid B Rabe, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Transplantation|February 15, 2021
Association of HHV-6 With Outcomes in CMV-seronegative Liver Transplant Recipients With CMV-seropositive Donors Receiving Preemptive Antiviral TherapyNina Singh, Drew J Winston, Raymund R Razonable, et al.
JAMA|April 15, 2020
Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical TrialNina Singh, Drew J Winston, Raymund R Razonable, et al.
Transplantation|April 18, 2020
Liver Transplantation in Patients With Pretransplant Aspergillus Colonization: Is It Safe to Proceed?Arpit Amin, Alfonso Molina, Lisa Quach, et al.
The New England Journal of Medicine|September 27, 2013
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantationFrancisco M Marty, Drew J Winston, Scott D Rowley, et al.
JCI Insight|August 5, 2024
Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxisDanniel Zamora, Sayan Dasgupta, Terry Stevens-Ayers, et al.
The Journal of Infectious Diseases|September 20, 2024
Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus InfectionSunwen Chou, Drew J Winston, Robin K Avery, et al.
Microorganisms|August 26, 2023
Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic InvestigationShangxin Yang, Ashrit Multani, Jacob M Garrigues, et al.
The New England Journal of Medicine|January 26, 2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropeniaOliver A Cornely, Johan Maertens, Drew J Winston, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2023
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With ValganciclovirGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Transplantation|May 16, 2014
Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic featuresDrew J Winston, Holenarasipur R Vikram, Ingrid B Rabe, et al.
Pageof 5